Qube Research & Technologies LTD Lemaitre Vascular Inc Transaction History
Qube Research & Technologies LTD
- $93.8 Billion
- Q2 2025
A detailed history of Qube Research & Technologies LTD transactions in Lemaitre Vascular Inc stock. As of the latest transaction made, Qube Research & Technologies LTD holds 173,839 shares of LMAT stock, worth $15.2 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
173,839
Previous 162,423
7.03%
Holding current value
$15.2 Million
Previous $13.6 Million
5.94%
% of portfolio
0.02%
Previous 0.02%
Shares
14 transactions
Others Institutions Holding LMAT
# of Institutions
303Shares Held
21.4MCall Options Held
0Put Options Held
0-
Black Rock Inc. New York, NY3.48MShares$303 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.6MShares$140 Million0.0% of portfolio
-
Conestoga Capital Advisors, LLC1.57MShares$137 Million2.22% of portfolio
-
Copeland Capital Management, LLC940KShares$82.1 Million1.75% of portfolio
-
Geneva Capital Management LLC915KShares$79.9 Million1.3% of portfolio
About LEMAITRE VASCULAR INC
- Ticker LMAT
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 21,962,900
- Market Cap $1.92B
- Description
- LeMaitre Vascular, Inc. designs, markets, sells, services, and supports medical devices and implants for the treatment of peripheral vascular disease worldwide. It offers angioscope, a fiberoptic catheter used for viewing the lumen of a blood vessel; embolectomy catheters to remove blood clots from arteries or veins; occlusion catheters that tem...